B-cells and Antibodies – B-cells make antibodies, which help your body recognise and fight infections. Smoking reduces the number of these cells and weakens their function. This means your body is ...

DelveInsight’s Natural Killer (NK)-Cell Lymphoma Pipeline report depicts a robust space with 100+ active players working to develop 140+ pipeline therapies for Natural Killer (NK)-Cell Lymphoma ...

In the current study, the scientists thought NK cells might also have a direct impact on the brain chemicals that modulate ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that members of its executive team will present and host 1x1 meetings at the upcoming ...

Innate Pharma is a trusted partner to biopharmaceutical companies such as Sanofi and AstraZeneca, as well as leading research ...

Long term follow-up data from the TELLOMAK Phase 2 trial in Sézary syndrome (SS) and mycosis fungoides (MF) will be presented at the ASCO Annual Meeting 2025. Long-term follow-up data from ...

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") announced the voting ...

As part of the event, Dr. Hertz will provide a corporate overview and business outlook. In addition to the moderated ...

Fintel reports that on May 20, 2025, Piper Sandler upgraded their outlook for ImmunityBio (NasdaqGS:IBRX) from Neutral to ...

LIfT BioSciences presents latest data on its first-in-class Immunomodulatory Alpha Neutrophils at International Society for ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") announced today that four abstracts with Innate's drugs in clinical development have been accepted for the American ...

Click here to register for the event. A live webcast of the fireside chat will be accessible on the Events page under the Investors section of the Company’s website ( gribio.com ).